公共自动体外除颤器的成本效益
该研究比较美国院外心脏骤停场景下公共AED策略与无AED策略的终身成本效益,基于文献综述构建模型,基础病例假设每台AED年心脏骤停发生率为20%。无AED策略产生1.63个QALY、成本28,964美元;AED策略额外获得0.26个QALY、增量成本13,793美元,增量成本效益比为每获得一个QALY花费53,797美元。在多项敏感性分析中AED策略均保持成本效益;概率敏感性分析显示,在支付意愿阈值分别为每QALY 50,000、100,000、150,000美元时,AED策略具有成本效益的场景比例分别为43%、85%、91%。作者结论认为公共AED在美国是具有成本效益的公共卫生干预,支持广泛推广。
要点
- 在美国院外心脏骤停模型中,公共AED策略相比无AED策略每获得一个QALY的增量成本效益比为53,797美元。
- AED策略额外获得0.26个QALY,增量成本为每人13,793美元;无AED策略为1.63个QALY、成本28,964美元。
- 每台AED年心脏骤停发生率仅在极低水平时才对增量成本效益比产生明显影响,基础病例假设为20%。
- 概率敏感性分析中,支付意愿阈值为每QALY 50,000、100,000、150,000美元时,AED策略具有成本效益的场景比例分别为43%、85%、91%。
- 作者认为公共AED是美国具有成本效益的公共卫生干预,支持广泛推广。
适用人群与场景
- 美国院外心脏骤停人群,比较公共AED策略与无AED策略的终身成本效益。
研究设计与关键结果
- 研究类型为成本效益分析,采用社会视角、终身时间 horizon,结果以每质量调整生命年(QALY)成本表示,模型输入基于文献综述。
- 基础病例假设每台AED年心脏骤停发生率为20%。
- 无AED策略:1.63个QALY,成本28,964美元;AED策略:额外0.26个QALY,增量成本13,793美元。
- AED策略增量成本效益比为每获得一个QALY花费53,797美元。
- 每台AED年心脏骤停发生率仅在极低水平时才对增量成本效益比有明显影响;在多项敏感性分析中AED策略均保持成本效益。
- 概率敏感性分析:支付意愿阈值为每QALY 50,000、100,000、150,000美元时,AED策略具有成本效益的场景比例分别为43%、85%、91%。
证据类型、等级与局限
- 证据类型:成本效益分析(基于文献综述的模型研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为公共AED在美国是具有成本效益的公共卫生干预,这些发现支持广泛传播公共AED。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Despite a consistent association with improved outcomes, public automated external defibrillators (AEDs) are rarely used in out-of-hospital cardiac arrest. One of the barriers towards increased use might be cost-effectiveness.
METHODS: We compared the cost-effectiveness of public AEDs to no AEDs for out-of-hospital cardiac arrest in the United States over a life-time horizon. The analysis assumed a societal perspective and results are presented as costs per quality-adjusted life year (QALY). Model inputs were based on reviews of the literature. For the base case, we modelled an annual cardiac arrest incidence per AED of 20%. A probabilistic sensitivity analysis was conducted to account for joint parameter uncertainty.
RESULTS: The no AED strategy resulted in 1.63 QALYs at a cost of $28,964. The AED strategy yielded an additional 0.26 QALYs for an incremental increase in cost of $13,793 per individual. The AED strategy yielded an incremental cost-effectiveness ratio of $53,797 per QALY gained. The yearly incidence of cardiac arrests occurring in the presence of an AED had minimal effect on the incremental cost-effectiveness ratio except at very low incidences. In several sensitivity analyses across a plausible range of health care and societal estimates, the AED strategy remained cost-effective. In the probabilistic sensitivity analysis, the AED strategy was cost-effective in 43%, 85%, and 91% of the scenarios at a willingness-to-pay threshold of $50,000, $100,000, and $150,000 per QALY gained, respectively.
CONCLUSION: Public AEDs are a cost-effective public health intervention in the United States. These findings support widespread dissemination of public AEDs.
参考来源
- Andersen LW, Holmberg MJ, Granfeldt A, et al. Cost-effectiveness of public automated external defibrillators. Resuscitation. 2019. PMID: 30926453. doi:10.1016/j.resuscitation.2019.03.029
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。